New drug trial targets painful lupus skin rash
Disease control
Recruiting now
This study is testing whether an experimental drug called VENT-03 can reduce the severity of skin rashes caused by lupus. About 24 adults with active lupus skin rashes will take either VENT-03 or a placebo for 4 weeks, then all will take VENT-03 for 8 more weeks. Researchers will…
Phase: PHASE2 • Sponsor: Ventus Therapeutics U.S., Inc. • Aim: Disease control
Last updated Apr 01, 2026 21:56 UTC